ABAlan Bogdanov

Alan Bogdanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan Bogdanov has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rolul uretritelor nongonococice de etiologie bacteriană în infertilitatea masculină

    by Iurii Arian, Daniela-Patricia Covali, Ion Dumbraveanu, Alan Bogdanov, Gabriela Scripnic, Constantin Tataru

    The article presents original data as well as a review of recent literature on the potential impact of male genital tract infections, particularly non-gonococcal urethritis on male infertility. The retrospective study included 200 patients from infertile couples who experienced unexplained infertility. They were separated into two groups: 100 patients with sexually transmitted infections and 100 patients with no infection. Spermograms, inflammatory state, and endocrine indicators were all examined in both groups. In 37 (37%) of the men, a single infection with Ureaplasma urealyticum/parvum was identified, in 24 (24%) with Gardnerella vaginalis, in 32 (32%) with both Ureaplasma urealiticum/parvum and Gardnerella vaginalis, in 9 (9%) with Mycoplasma hominis, and in 8 (8%) with Mycoplasma genitalium. Comparative analysis of the groups revealed statistically significant differences (p < 0.05) in ejaculate volume, pH, total sperm count, concentration, total motility, progressive motility, and sperm vitality, with significantly lower values in the study group compared to the control group. Infection with Ureaplasma spp., either alone or in combination with other non-gonococcal infections, has a significant impact on ejaculate volume, pH, total sperm count, concentration, vitality, total motility, and progressive motility of spermatozoa compared to the control group.

  • Open Access

    Multiparametric descriptive and comparative analyses between fertile versus infertile men with severe oligozoospermia and azoospermia

    by Iurii Arian, Alan Bogdanov, Karabacak Ozcan Yasin, Ion I. Dumbrăveanu, Ion Dumbraveanu, Andrei Chiriac

    Male infertility represents a major global health concern, often associated with conditions such as severe oligoasthenoteratozoospermia and azoospermia. The aim of the study was to compare clinical, biochemical, and genetic characteristics between infertile men and fertile controls. A prospective case-control study was conducted involving 180 participants, including 90 infertile men (45 with severe oligoasthenoteratozoospermia and 45 with azoospermia) and 90 fertile controls. Semen analysis, testicular ultrasound, vitamin D levels, and genetic testing.were performed. In men with severe oligoasthenoteratozoospermia, significantly reduced mean values were observed for sperm concentration (1.77±2 million/mL), total sperm count (5.59±8 million), total motility (12.64±16%), progressive motility (7.93±12%), vitality (13.64±18%), and normal morphology (1.02±2%) compared to controls. Vitamin D levels were slightly higher in the study group (29.37±9.3 ng/mL) than in controls (25.38±10.2 ng/mL). Average testicular volumes were 12.50±5.47 mL (right) and 12.30±5.09 mL (left). Abnormal echotexture and echogenicity were noted in 24.6% and 31.5% of right testes and 15.6% and 25.5% of left testes, respectively. Y chromosome microdeletions (sY242, sY1291, sY255, sY254) were identified in 4.4% of cases. An abnormal karyotype was found in 7.8% of infertile participants, while 92.2% had a normal karyotype. Compared with fertile men, severe oligoasthenozoospermia and azoospermia show marked alterations in semen, testicular, genetic, and endocrine parameters.

  • Open Access

    Provocări actuale în diagnosticul și tratamentul deficitului de testosteron la bărbații de vârstă reproductivă

    by Iurii Arian, Ion Dumbraveanu, Victoria Ghenciu, Alan Bogdanov, Mariana Creciun, Emil Ceban

    Currently, an increasing number of young and middle-aged men are seeking treatment for symptoms related to low testosterone levels, which include depression, chronic fatigue, low libido, erectile dysfunction and/or infertility. In situations where conceiving a child is not a short- or medium-term goal, the preservation of reproductive function needs to be considered in the context of the treatment offered. Testosterone deficiency is often of unknown origin especially in men of reproductive age, and the choice of treatment method becomes even more difficult, in the context where the scientific evidence and degree of recommendation of various treatments is weak. Literature review was performed using major databases including PubMed, Hinari, SpringerLink and Scopus (Elsevier). One third of infertile men under the age of 50 were found to be hypogonadal. Correlation of spermogram result with testosterone level identified deficiency in 16.7% of men with obstructive azoospermia, 45% of men with non-obstructive azoospermia, 42.9% of men with oligozoospermia and/or asthenozoospermia and 35.3% of men with normal sperm parameters. Testosterone replacement therapy, although effective in addressing most symptoms of hypogonadism, has negative effects on testicular function. Counseling should include a thorough discussion of risks and benefits with an emphasis on spermatogenesis suppression for men of reproductive age who wish to maintain their reproductive potential.